Page 26 - Pfizer
Cost, timeline: Facts about Pfizer-BioNTech's '90% effective' Covid vaccine
The companies said the vaccine was more than 90% effective and they have so far found no serious safety concerns, priming it for possible speedy regulatory approvals
 "Cost, timeline: Facts about Pfizer-BioNTech's '90% effective' Covid vaccine")
Sputnik V vaccine is over 90% effective, says Russia's health ministry
The comments followed a statement earlier on Monday by vaccine developers Pfizer Inc and BioNTech, who said their experimental Covid-19 vaccine was more than 90% effective
 "Sputnik V vaccine is over 90% effective, says Russia's health ministry")
Biden focuses on tackling US coronavirus pandemic, hails vaccine progress
He labeled as "great news" Pfizer Inc's announcement on Monday that its experimental Covid-19 vaccine was more than 90% effective
 "Biden focuses on tackling US coronavirus pandemic, hails vaccine progress")
EU drug regulator says it is assessing early data from Pfizer Covid vaccine
The European Medicines Agency (EMA) started a rolling review of data from trials on the vaccine in early October.
 "EU drug regulator says it is assessing early data from Pfizer Covid vaccine")
Pfizer, BioNTech say their Covid-19 vaccine is more than 90% effective
Pfizer and BioNTech SE are first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine
 "Pfizer, BioNTech say their Covid-19 vaccine is more than 90% effective")
Pfizer's Covid vaccine candidate prevents 90% of infections in large study
The findings are based on an interim analysis conducted after 94 participants contracted Covid-19
Pfizer says no Covid vaccine data yet, unlikely to come before US elections
An independent panel will conduct the first analysis when it reaches 32 infections.
 "Pfizer says no Covid vaccine data yet, unlikely to come before US elections")
UK starts real-time review of Moderna's Covid-19 vaccine candidate
Moderna said earlier this month it was going to apply for real-time reviews of its experimental Covid-19 vaccine to Europe, following rolling reviews of shots of its rivals Pfizer Inc and AstraZeneca
 "UK starts real-time review of Moderna's Covid-19 vaccine candidate")
Drugmaker Pfizer not yet ready to release Covid-19 vaccine data
Pfizer said in a presentation that the independent monitor which will determine whether or not the trial has been successful has not conducted any interim efficacy analyses yet
 "Drugmaker Pfizer not yet ready to release Covid-19 vaccine data")
Pfizer says earliest US filing for Covid-19 vaccine would be late November
People around the world are counting on a vaccine to control the spread of the coronavirus, which has killed more than a million people and ravaged the global economy
Pfizer confirms possible November coronavirus vaccine application
Safety review dictates the timeline, with the Food and Drug Administration requiring that at least half the people in the study be watched for side effects for two months
 "Pfizer confirms possible November coronavirus vaccine application")
Pfizer could apply for emergency use of Covid-19 vaccine by late Nov
It would be the first time that Pfizer or any other leading Western vaccine developer provided such a specific timeline.
 "Pfizer could apply for emergency use of Covid-19 vaccine by late Nov")
New Zealand signs deal with Pfizer, BioNTech for coronavirus vaccine
SYDNEY (Reuters) - The New Zealand government signed a deal on Monday to buy 1.5 million COVID-19 vaccines from Pfizer Inc and Germany's BioNTech <22UAy.F>, with delivery potentially as early as the first quarter of 2021.
EU health regulator reviewing Pfizer-BioNTech Covid-19 vaccine in real time
The announcement by the European Medicines Agency (EMA) could speed up the process of approving a successful vaccine in the bloc
Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial
Pfizer's German development partner BioNTech on Thursday joined other leading Covid-19 vaccine developers in ruling out participation in British plans to test experimental inoculations
 "Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial")
Johnson & Johnson kicks off giant study of single shot Covid-19 vaccine
J&J became the fourth vaccine maker to move its candidate into late-stage human studies in the US
Trump suggests Pfizer could win first US approval for Covid-19 vaccine
'Pfizer's doing really well', Trump said in an interview
 "Trump suggests Pfizer could win first US approval for Covid-19 vaccine")
Trump suggests Pfizer could win Covid vaccine approval, J&J to come later
WASHINGTON (Reuters) - U.S. President Donald Trump on Monday suggested Pfizer Inc could secure the first U.S. approval of a COVID-19 vaccine in coming weeks, saying a contender by Johnson & Johnson could come later.
Moderna and Pfizer reveal secret blueprints for virus vaccine trials
The companies, Moderna and Pfizer, revealed details about how participants are being selected and monitored
 "Moderna and Pfizer reveal secret blueprints for virus vaccine trials")
Pfizer vaccine trial bets on early win against coronavirus, documents show
Pfizer's clinical trial protocol outlines for the company, scientists and regulators how the drugmaker could show that its vaccine meets efficacy and safety standards set by USFDA
